Literature DB >> 477220

Increased turnover of muscle contractile proteins in Duchenne muscular dystrophy as assessed by 3-methylhistidine and creatinine excretion.

F J Ballard, F M Tomas, L M Stern.   

Abstract

1. Myofibrillar protein degradation has been measured in patients with Duchenne muscular dystrophy, normal boys, adult males and Duchenne carriers by the rate of 3-methylhistidine excretion after transfer of subjects to a meat-free diet. 2. Although absolute rates of protein breakdown are lower in Duchenne patients, expression of the data to allow for differences in muscle mass gives fractional degradation rates 2--3 times higher than in age-matched controls. 3. Fractional rates of muscle protein synthesis are increased in the Duchenne patients to almost the same extent as protein breakdown. 4. Rates of muscle protein breakdown in obligate and presumed carriers of the Duchenne gene are not different from controls.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 477220     DOI: 10.1042/cs0560347

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  5 in total

Review 1.  Contractile proteins in muscle disease.

Authors:  P Cummins
Journal:  J Muscle Res Cell Motil       Date:  1983-02       Impact factor: 2.698

2.  Clinical usefulness of urinary 3-methylhistidine excretion in indicating muscle protein breakdown.

Authors:  M Elia; A Carter; S Bacon; C G Winearls; R Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-31

3.  Proteases in normal and diseased human skeletal muscle: a preliminary histochemical survey.

Authors:  M G White; P J Stoward; K N Christie; J M Anderson
Journal:  Histochem J       Date:  1985-07

4.  Activation of the intramyofibral autophagic-lysosomal system in muscular dystrophy.

Authors:  E Kominami; I Kunio; N Katunuma
Journal:  Am J Pathol       Date:  1987-06       Impact factor: 4.307

5.  Differential degradation of [35S]methionine polypeptides in Duchenne muscular dystrophy skin fibroblasts in vitro.

Authors:  H P Rodemann; K Bayreuther
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.